Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VER
4901
CALL
DELISTED
VEREIT, Inc.
VER
| $87K | ﹤0.01% |
2,040
-1,300
| -39% | -$56K |
|
|
UNT
4902
PUT
DELISTED
UNIT Corporation
UNT
| $87K | ﹤0.01% |
+3,600
| New | +$92K |
|
|
BETR
4903
DELISTED
Amplify Snack Brands, Inc.
BETR
| $87K | ﹤0.01% |
10,291
-812
| -7% | -$7.82K |
|
|
SNAK
4904
DELISTED
Inventure Foods, Inc.
SNAK
| $87K | ﹤0.01% |
+19,817
| New | +$119K |
|
4905
American Superconductor
AMSC
$1.42B
| $86K | ﹤0.01% |
12,616
+11,599
| +1,141% | +$78.1K |
|
4906
PUT
Coeur Mining
CDE
$15.4B
| $86K | ﹤0.01% |
10,700
-15,200
| -59% | -$145K |
|
4907
China Yuchai International
CYD
$1.77B
| $86K | ﹤0.01% |
+4,658
| New | +$71.7K |
|
4908
PUT
iShares MSCI Italy ETF
EWI
$1.01B
| $86K | ﹤0.01% |
3,350
-34,750
| -91% | -$850K |
|
4909
CALL
H&R Block
HRB
$5.58B
| $86K | ﹤0.01% |
3,700
-351,400
| -99% | -$7.86M |
|
4910
Matrix Service
MTRX
$326M
| $86K | ﹤0.01% |
5,195
-26,993
| -84% | -$507K |
|
4911
Regenxbio
RGNX
$620M
| $86K | ﹤0.01% |
4,492
-1,063
| -19% | -$20.5K |
|
4912
PUT
TherapeuticsMD
TXMD
$23.5M
| $86K | ﹤0.01% |
+240
| New | +$74.3K |
|
|
BKCC
4913
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $86K | ﹤0.01% |
11,376
+11,322
| +20,967% | +$84.9K |
|
|
FELP
4914
DELISTED
Foresight Energy LP
FELP
| $86K | ﹤0.01% |
13,592
+13,500
| +14,674% | +$92K |
|
|
MSL
4915
DELISTED
Midsouth Bancorp, Inc.
MSL
| $86K | ﹤0.01% |
+5,600
| New | +$80.6K |
|
4916
iPath Select MLP ETN
ATMP
$639M
| $85K | ﹤0.01% |
3,575
| – | – |
|
4917
CALL
Chemours
CC
$2.5B
| $85K | ﹤0.01% |
2,200
-1,660
| -43% | -$50K |
|
4918
Mueller Industries
MLI
$14.7B
| $85K | ﹤0.01% |
10,016
+6,672
| +200% | +$64.9K |
|
4919
PUT
Patterson-UTI
PTEN
$3.98B
| $85K | ﹤0.01% |
3,500
-4,900
| -58% | -$132K |
|
4920
Triumph Financial Inc
TFIN
$1.81B
| $85K | ﹤0.01% |
+3,271
| New | +$86.7K |
|
|
SSI
4921
DELISTED
Stage Stores Inc
SSI
| $85K | ﹤0.01% |
32,827
+32,344
| +6,696% | +$86.9K |
|
4922
Ardmore Shipping
ASC
$710M
| $84K | ﹤0.01% |
10,480
+10,320
| +6,450% | +$75.9K |
|
4923
Barings BDC
BBDC
$864M
| $84K | ﹤0.01% |
+4,418
| New | +$84.7K |
|
4924
PUT
Cabot Corp
CBT
$4.54B
| $84K | ﹤0.01% |
1,400
+500
| +56% | +$28.4K |
|
4925
Performance Shipping
PSHG
$21.6M
| – | – |
0
| – | – |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.